These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15477660)

  • 1. Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infection.
    Wickham S; Ash J; Lane TE; Carr DJ
    Immunol Res; 2004; 30(2):191-200. PubMed ID: 15477660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.
    Noisakran S; Campbell IL; Carr DJ
    J Immunol; 1999 Apr; 162(7):4184-90. PubMed ID: 10201945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system.
    Carr DJ; Campbell IL
    Viral Immunol; 2006; 19(4):741-6. PubMed ID: 17201669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection.
    Carr DJ; Chodosh J; Ash J; Lane TE
    J Virol; 2003 Sep; 77(18):10037-46. PubMed ID: 12941914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid DNA encoding IFN-alpha 1 antagonizes herpes simplex virus type 1 ocular infection through CD4+ and CD8+ T lymphocytes.
    Noisakran S; Carr DJ
    J Immunol; 2000 Jun; 164(12):6435-43. PubMed ID: 10843699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection.
    Wuest T; Farber J; Luster A; Carr DJ
    Cell Immunol; 2006 Oct; 243(2):83-9. PubMed ID: 17296171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-alpha1 transgene efficacy.
    Noisakran S; Härle P; Carr DJ
    Virology; 2001 Apr; 283(1):69-77. PubMed ID: 11312663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
    Noisakran SJ; Carr DJ
    Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.
    Mott KR; Wechsler SL; Ghiasi H
    Mol Vis; 2010 Oct; 16():2153-62. PubMed ID: 21139679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasmid construct encoding murine interferon beta antagonizes the replication of herpes simplex virus type I in vitro and in vivo.
    Cui B; Carr DJ
    J Neuroimmunol; 2000 Aug; 108(1-2):92-102. PubMed ID: 10900342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical application of the cornea post-infection with plasmid DNA encoding interferon-alpha1 but not recombinant interferon-alphaA reduces herpes simplex virus type 1-induced mortality in mice.
    Noisakran S; Carr DJ
    J Neuroimmunol; 2001 Dec; 121(1-2):49-58. PubMed ID: 11730939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?
    Noisakran S; Carr DJ
    Immunol Res; 2001; 24(1):1-11. PubMed ID: 11485206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Battle with herpes for 37 years].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1.
    Pasieka TJ; Cilloniz C; Lu B; Teal TH; Proll SC; Katze MG; Leib DA
    J Virol; 2009 Mar; 83(5):2075-87. PubMed ID: 19109391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection.
    Härle P; Cull V; Guo L; Papin J; Lawson C; Carr DJ
    Antiviral Res; 2002 Oct; 56(1):39-49. PubMed ID: 12323398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
    Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
    J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y; Ghiasi H
    J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2.
    Carr DJ; Tomanek L; Silverman RH; Campbell IL; Williams BR
    J Virol; 2005 Jul; 79(14):9341-5. PubMed ID: 15994831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10.
    Wuest T; Austin BA; Uematsu S; Thapa M; Akira S; Carr DJ
    J Neuroimmunol; 2006 Oct; 179(1-2):46-52. PubMed ID: 16884784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN-alpha 2.
    Härle P; Lauret E; Pitha PM; De Maeyer E; Carr DJ
    Virology; 2001 Nov; 290(2):237-48. PubMed ID: 11883188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.